A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Hlavní autor: | Islam, Nahidul |
---|---|
Další autoři: | Talukder, Mesbah |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2023
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/22025 |
Podobné jednotky
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
Autor: Afroza, Halima
Vydáno: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
Autor: Moya, Amena Khatun
Vydáno: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
Autor: Bishakha, Adwiza Chakraborty
Vydáno: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
Autor: Islam, S.M. Zahidul
Vydáno: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
Autor: Khandker, Tahia Anjum
Vydáno: (2024)